Home/LIPAC Oncology/Ramachandran “TR” Thirucote, PhD

R“

Ramachandran “TR” Thirucote, PhD

Chairman & Chief Executive Officer

Therapeutic Areas

LIPAC Oncology Pipeline

Drug	Indication	Phase
LiPax	Non-Muscle Invasive Bladder Cancer (NMIBC)	Phase 2

Leadership Team at LIPAC Oncology

Michael Oefelein, MD, PhD, FACE

Chief Medical Officer

View full LIPAC Oncology profile